New drug for fatty liver enters first human safety test
NCT ID NCT07214870
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine called NNC4005-0001 to see if it is safe and tolerable for people with extra body weight and too much fat in the liver. About 60 adults will get either the medicine or a placebo (a dummy pill) just once. The study lasts about 7 to 8 months and focuses on side effects and how the drug moves through the body.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Altasciences Clinical Company, Inc
RECRUITINGMontreal, Quebec, H3P 3P1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden liver danger in Cushing's syndrome may reverse after cortisol cure
- Orange peel supplement tested for fat loss in overweight adults
- Reishi mushroom tested as fatty liver treatment in new study
- New scanner aims to spot fatty liver without needles
- Scientists probe body tissue to unlock secrets of weight loss surgery
- Old heart drug could be new hope against fatty liver